EGFR and non-small cell lung carcinoma: Receiver operating characteristic (ROC) curve analysis was performed to evaluate the potential applications of circulating plasma miR-107, miR-122, and miR-195 as diagnostic markers for NSCLC patients with EGFR-sensitive mutations.